Entero Healthcare Solutions Future Growth
Future criteria checks 4/6
Entero Healthcare Solutions is forecast to grow earnings and revenue by 31.9% and 18.4% per annum respectively. EPS is expected to grow by 31.9% per annum. Return on equity is forecast to be 14% in 3 years.
Key information
31.9%
Earnings growth rate
31.87%
EPS growth rate
| Healthcare earnings growth | 26.1% |
| Revenue growth rate | 18.4% |
| Future return on equity | 13.95% |
| Analyst coverage | Low |
| Last updated | 27 May 2026 |
Recent future growth updates
Entero Healthcare Solutions Limited Just Missed Earnings - But Analysts Have Updated Their Models
Shareholders might have noticed that Entero Healthcare Solutions Limited ( NSE:ENTERO ) filed its yearly result this...Entero Healthcare Solutions Limited Just Missed EPS By 25%: Here's What Analysts Think Will Happen Next
Entero Healthcare Solutions Limited ( NSE:ENTERO ) came out with its third-quarter results last week, and we wanted to...Recent updates
Entero Healthcare Solutions Limited Just Missed Earnings - But Analysts Have Updated Their Models
Shareholders might have noticed that Entero Healthcare Solutions Limited ( NSE:ENTERO ) filed its yearly result this...
ENTERO: Board Decisions And Option Grants Will Shape A Balanced Outlook
Analysts have revised their 12 month price target on Entero Healthcare Solutions from ₹1,497 to ₹1,410.50, citing updated assumptions around revenue growth, profit margins, discount rate, and future P/E. What's in the News A board meeting is scheduled for February 12, 2026 at 15:00 Indian Standard Time to consider and approve the unaudited standalone and consolidated financial results for the quarter and nine months ended December 31, 2025, along with a limited review (company filing).Entero Healthcare Solutions Limited Just Missed EPS By 25%: Here's What Analysts Think Will Happen Next
Entero Healthcare Solutions Limited ( NSE:ENTERO ) came out with its third-quarter results last week, and we wanted to...Entero Healthcare Solutions (NSE:ENTERO) Has A Pretty Healthy Balance Sheet
Warren Buffett famously said, 'Volatility is far from synonymous with risk.' When we think about how risky a company...India Urbanization And Market Consolidation Will Expand Pharma Distribution
Key Takeaways Rapid network scale and product expansion are driven by industry consolidation in a fragmented market and continued acquisition strategy. Operational efficiencies, margin gains, and cash flow improvement stem from proprietary tech, higher-margin segments, and a gradual shift to organic growth.Entero Healthcare Solutions Limited Just Beat Analyst Forecasts, And Analysts Have Been Updating Their Predictions
NSEI:ENTERO 1 Year Share Price vs Fair Value Explore Entero Healthcare Solutions's Fair Values from the Community and...Here's Why Entero Healthcare Solutions (NSE:ENTERO) Can Manage Its Debt Responsibly
Legendary fund manager Li Lu (who Charlie Munger backed) once said, 'The biggest investment risk is not the volatility...Entero Healthcare Solutions Limited Earnings Missed Analyst Estimates: Here's What Analysts Are Forecasting Now
There's been a notable change in appetite for Entero Healthcare Solutions Limited ( NSE:ENTERO ) shares in the week...The Return Trends At Entero Healthcare Solutions (NSE:ENTERO) Look Promising
There are a few key trends to look for if we want to identify the next multi-bagger. Firstly, we'll want to see a...Entero Healthcare Solutions Limited (NSE:ENTERO) Looks Just Right With A 25% Price Jump
Entero Healthcare Solutions Limited ( NSE:ENTERO ) shares have had a really impressive month, gaining 25% after a shaky...With EPS Growth And More, Entero Healthcare Solutions (NSE:ENTERO) Makes An Interesting Case
Investors are often guided by the idea of discovering 'the next big thing', even if that means buying 'story stocks...What You Can Learn From Entero Healthcare Solutions Limited's (NSE:ENTERO) P/E
With a price-to-earnings (or "P/E") ratio of 56.7x Entero Healthcare Solutions Limited ( NSE:ENTERO ) may be sending...Analysts Have Been Trimming Their Entero Healthcare Solutions Limited (NSE:ENTERO) Price Target After Its Latest Report
It's been a sad week for Entero Healthcare Solutions Limited ( NSE:ENTERO ), who've watched their investment drop 14...Revenue Beat: Entero Healthcare Solutions Limited Beat Analyst Estimates By 9.0%
Last week, you might have seen that Entero Healthcare Solutions Limited ( NSE:ENTERO ) released its second-quarter...Earnings and Revenue Growth Forecasts
| Date | Revenue | Earnings | Free Cash Flow | Cash from Op | Avg. No. Analysts |
|---|---|---|---|---|---|
| 3/31/2029 | 116,664 | 3,184 | 2,791 | 3,381 | 2 |
| 3/31/2028 | 97,615 | 2,403 | 531 | 2,348 | 4 |
| 3/31/2027 | 81,437 | 1,646 | 698 | 1,978 | 3 |
| 3/31/2026 | 65,912 | 1,150 | 287 | 962 | N/A |
| 12/31/2025 | 60,203 | 1,127 | N/A | N/A | N/A |
| 9/30/2025 | 56,728 | 1,105 | -264 | -91 | N/A |
| 6/30/2025 | 54,026 | 1,025 | N/A | N/A | N/A |
| 3/31/2025 | 50,958 | 948 | -882 | -769 | N/A |
| 12/31/2024 | 47,909 | 901 | N/A | N/A | N/A |
| 9/30/2024 | 44,245 | 714 | -873 | -790 | N/A |
| 6/30/2024 | 41,201 | 529 | N/A | N/A | N/A |
| 3/31/2024 | 39,223 | 391 | -420 | -366 | N/A |
| 12/31/2023 | 37,753 | 144 | N/A | N/A | N/A |
| 9/30/2023 | 36,117 | 110 | -655 | -603 | N/A |
| 6/30/2023 | 34,074 | 3 | N/A | N/A | N/A |
| 3/31/2023 | 33,002 | -116 | -508 | -453 | N/A |
| 3/31/2022 | 25,221 | -299 | -451 | -353 | N/A |
| 3/31/2021 | 17,731 | -155 | -782 | -687 | N/A |
| 3/31/2020 | 13,496 | 9 | -815 | -365 | N/A |
Analyst Future Growth Forecasts
Earnings vs Savings Rate: ENTERO's forecast earnings growth (31.9% per year) is above the savings rate (6.9%).
Earnings vs Market: ENTERO's earnings (31.9% per year) are forecast to grow faster than the Indian market (16.1% per year).
High Growth Earnings: ENTERO's earnings are expected to grow significantly over the next 3 years.
Revenue vs Market: ENTERO's revenue (18.4% per year) is forecast to grow faster than the Indian market (10.9% per year).
High Growth Revenue: ENTERO's revenue (18.4% per year) is forecast to grow slower than 20% per year.
Earnings per Share Growth Forecasts
Future Return on Equity
Future ROE: ENTERO's Return on Equity is forecast to be low in 3 years time (14%).
Discover growth companies
Company Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2026/06/23 04:13 |
| End of Day Share Price | 2026/06/23 00:00 |
| Earnings | 2026/03/31 |
| Annual Earnings | 2026/03/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* Example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.
Analyst Sources
Entero Healthcare Solutions Limited is covered by 4 analysts. 4 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
| Analyst | Institution |
|---|---|
| Nitin Agarwal | DAM Capital Advisors |
| Rahul Jeewani | IIFL Research |
| Anshuman Gupta | Investec Bank plc (UK) |